ortho-Bromophenylpiperazine

*ortho*-Bromophenylpiperazine
Clinical data
Other names	oBPP; 2-Bromophenylpiperazine; 2-BPP; 2-Bromo-PP
Drug class	Serotonin–norepinephrine–dopamine releasing agent
Identifiers
	IUPAC name 1-(2-bromophenyl)piperazine;
CAS Number	1011-13-8;
PubChem CID	2757153;
ChemSpider	2037913;
CompTox Dashboard (EPA)	DTXSID60373747 ;
ECHA InfoCard	100.199.072
Chemical and physical data
Formula	C10H13BrN2
Molar mass	241.132 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CN(CCN1)C2=CC=CC=C2Br;
	InChI InChI=1S/C10H13BrN2/c11-9-3-1-2-4-10(9)13-7-5-12-6-8-13/h1-4,12H,5-8H2; Key:JVTRURBMYILQDA-UHFFFAOYSA-N;

ortho-Bromophenylpiperazine (oBPP), also known as 2-bromophenylpiperazine (2-BPP), is a monoamine releasing agent of the phenylpiperazine family.^[1] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC₅₀Tooltip half-maximal effective concentration values of 132 nM for serotonin, 33 nM for norepinephrine, and 250 nM for dopamine in rat brain synaptosomes.^[1] The drug was first described in the scientific literature by 2012.^[1]

References

^ ^a ^b ^c Severinsen K, Kraft JF, Koldsø H, Vinberg KA, Rothman RB, Partilla JS, Wiborg O, Blough B, Schiøtt B, Sinning S (September 2012). "Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters". ACS Chem Neurosci. 3 (9): 693–705. doi:10.1021/cn300040f. PMC 3447394. PMID 23019496.

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.